Bastide Le Confort Médical SA (EPA:BLC)
France · Delayed Price · Currency is EUR 19.30
-0.28 (-1.43%)
Nov 12, 2026, 10:00 AM CET
EPA:BLC Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 482.39 | 448.08 | 461.87 | 508.03 | 468.3 | |
Revenue Growth | 7.66% | -2.99% | -9.09% | 8.48% | 5.46% |
Cost of Revenue | 156.05 | 146.03 | 153.25 | 174.3 | 161.5 |
Gross Profit | 326.35 | 302.05 | 308.63 | 333.73 | 306.8 |
Selling, General & Admin | 214.85 | 200.91 | 212.34 | 229.68 | 207.42 |
Amortization of Goodwill & Intangibles | 60.63 | 55.89 | 55.01 | 58.8 | - |
Other Operating Expenses | 3.64 | 2.97 | 2.75 | 2.43 | 4.4 |
Operating Expenses | 279.12 | 259.77 | 270.11 | 290.91 | 267.87 |
Operating Income | 47.23 | 42.28 | 38.52 | 42.82 | 38.93 |
Interest Expense | -23.35 | -30.62 | -26.88 | -16.59 | -10.2 |
Earnings From Equity Investments | - | 0.03 | - | 0.04 | 0.01 |
Other Non Operating Income (Expenses) | -0.73 | 2.04 | 5.31 | 2.66 | -1.34 |
EBT Excluding Unusual Items | 23.15 | 13.72 | 16.94 | 28.93 | 27.4 |
Merger & Restructuring Charges | -1.03 | 0.13 | -0.68 | - | -1.85 |
Asset Writedown | -3.01 | -1.11 | 0.75 | -0.03 | -0.04 |
Legal Settlements | -2.07 | - | - | - | -1.33 |
Other Unusual Items | -2.48 | -4.72 | -3.9 | -6.13 | -3.17 |
Pretax Income | 14.58 | 8.02 | 13.12 | 22.77 | 21.02 |
Income Tax Expense | 4.58 | 5.55 | 6.61 | 5.96 | 5.93 |
Earnings From Continuing Operations | 10 | 2.48 | 6.51 | 16.81 | 15.09 |
Earnings From Discontinued Operations | 49.69 | -0.92 | -5.3 | -4.02 | -0.76 |
Net Income to Company | 59.69 | 1.56 | 1.21 | 12.79 | 14.33 |
Minority Interest in Earnings | -1.59 | -1.03 | -2.11 | -0.74 | -0.65 |
Net Income | 58.1 | 0.53 | -0.9 | 12.05 | 13.68 |
Net Income to Common | 58.1 | 0.53 | -0.9 | 12.05 | 13.68 |
Net Income Growth | 10903.41% | - | - | -11.94% | 1.70% |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 7 |
Shares Change | 1.26% | -0.04% | 0.04% | 7.66% | 0.22% |
EPS (Basic) | 7.78 | 0.07 | -0.12 | 1.62 | 1.86 |
EPS (Diluted) | 7.23 | 0.07 | -0.11 | 1.52 | 1.86 |
EPS Growth | 10228.57% | - | - | -18.28% | 1.64% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 55.68 | 27.68 | 24.46 | 52.05 | 3.59 |
Free Cash Flow Per Share | 6.93 | 3.49 | 3.08 | 6.56 | 0.49 |
Dividend Per Share | 0.410 | - | - | - | - |
Dividend Growth | 51.85% | - | - | - | - |
Gross Margin | 67.65% | 67.41% | 66.82% | 65.69% | 65.51% |
Operating Margin | 9.79% | 9.44% | 8.34% | 8.43% | 8.31% |
Profit Margin | 12.04% | 0.12% | -0.19% | 2.37% | 2.92% |
Free Cash Flow Margin | 11.54% | 6.18% | 5.29% | 10.24% | 0.77% |
EBITDA | 87.31 | 82.05 | 75.16 | 82.93 | 79.51 |
EBITDA Margin | 18.10% | 18.31% | 16.27% | 16.32% | 16.98% |
D&A For EBITDA | 40.08 | 39.77 | 36.65 | 40.11 | 40.58 |
EBIT | 47.23 | 42.28 | 38.52 | 42.82 | 38.93 |
EBIT Margin | 9.79% | 9.44% | 8.34% | 8.43% | 8.31% |
Effective Tax Rate | 31.43% | 69.16% | 50.40% | 26.18% | 28.21% |